The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Veletri 0.5 Milligram Powder for Solution for Infusion

Janssen-Cilag International NVPA0885/001/001

Main Information

Trade NameVeletri 0.5 Milligram Powder for Solution for Infusion
Active SubstancesEpoprostenol
Dosage FormPowder for solution for infusion
Licence HolderJanssen-Cilag International NV
Licence NumberPA0885/001/001

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC09 epoprostenol


License statusAuthorised
Licence Issued16/09/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back